Oculeve
acquired by AllerganSouth San Francisco, US · Founded 2011 · 1 known investors
Ophthalmology; acquired by Allergan
Healthtech
Founders & leadership
DM
D. Michael Ackermann, PhDNamed on SEC filing
SW
Steve WaiteNamed on SEC filing
BB
Brook ByersNamed on SEC filing
MS
Mark S. Blumenkranz, MDNamed on SEC filing
AB
Ali BehbahaniNamed on SEC filing
WJ
William J. Link, PhDNamed on SEC filing
JL
James LoudinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$16.6M disclosed across 1 round · 2014
▶$16.6MraisedMar 2014 · 8 investors · Other Health CareRule 506(b)
▶$16.6MraisedMar 2014 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- D. Michael Ackermann, PhDExecutive Officer, Director
- Steve WaiteDirector
- Brook ByersDirector
- Mark S. Blumenkranz, MDDirector
- Ali BehbahaniDirector
- William J. Link, PhDDirector
- James LoudinExecutive Officer
- Offering amount
- $16.6M
- Amount sold
- $16.6M
- Minimum investment
- $1
- First sale
- Mar 2014
- Incorporated
- Corporation, California, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Oculeve do?
- Ophthalmology; acquired by Allergan
- Who are Oculeve's investors?
- Oculeve's investors include Kleiner Perkins.
- How much funding has Oculeve raised?
- Oculeve has disclosed $16.6M raised across 1 round.
- Who acquired Oculeve?
- Oculeve was acquired by Allergan.
- Where is Oculeve headquartered?
- Oculeve is headquartered in South San Francisco, US.